Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2013

Aug 14, 2013

32870_dirs_2013-08-14_39ed1001-859e-48a9-92f2-236ffa2c9360.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2013-08-12

Reporting Person: Labinger Barry (EVP, Biosciences Div.)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct

Footnotes

F1: No securities are beneficially owned.